发明名称 COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA AND CANCER
摘要 <p>Formula (I): Where R&lt;SUP&gt;1&lt;/SUP&gt; is an optionally substituted C&lt;SUB&gt;3&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; hydrocarbyl group (preferably a cyclic alkyl group), an optionally substituted heterocyclic group, an optionally substituted aromatic group or an optionally substituted heteroaromatic group; R is a C(O)&lt;SUB&gt;y&lt;/SUB&gt;R' group (preferably forming an optionally substituted C&lt;SUB&gt;2&lt;/SUB&gt;-C&lt;SUB&gt;5&lt;/SUB&gt; acyl group), or a S(O)&lt;SUB&gt;x&lt;/SUB&gt;R' group, where y is 0 or 1 and x is 0, 1 or 2 and R' is H or an optionally substituted C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; alkyl group, or R' is an optionally substituted C&lt;SUB&gt;5&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; cycloalkyl group, an optionally substituted heterocyclic group, an optionally substituted aromatic group or an optionally substituted heteroaromatic group; R&lt;SUP&gt;5&lt;/SUP&gt;, R&lt;SUP&gt;6&lt;/SUP&gt;, R&lt;SUP&gt;7&lt;/SUP&gt;, R&lt;SUP&gt;8&lt;/SUP&gt;, R&lt;SUP&gt;9&lt;/SUP&gt; and R&lt;SUP&gt;10&lt;/SUP&gt; are each independently selected from H, an optionally substituted C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; hydrocarbyl group, including a C&lt;SUB&gt;5&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; cycloalkyl group, an optionally substituted heterocyclic group, an optionally substituted aromatic group or an optionally substituted heteroaromatic group, or R&lt;SUP&gt;5&lt;/SUP&gt; and R&lt;SUP&gt;6&lt;/SUP&gt;, R&lt;SUP&gt;7&lt;/SUP&gt; and R&lt;SUP&gt;8&lt;/SUP&gt; or R&lt;SUP&gt;9&lt;/SUP&gt; and R&lt;SUP&gt;10&lt;/SUP&gt; together form a keto (C=O) group; R&lt;SUP&gt;N&lt;/SUP&gt; is H, an optionally substituted C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; hydrocarbyl group, an optionally substituted heterocyclic group, an optionally substituted aromatic group, or an optionally substituted heteroaromatic group; A is Formula (II): a Formula (III): group, or a Formula (IV) or Formula (V) group, where Z is N, O or S; R&lt;SUP&gt;a&lt;/SUP&gt; is H, a C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;12&lt;/SUB&gt; optionally substituted hydrocarbyl group or an optionally substituted aromatic group; n is from 0 to 3; and pharmaceutically acceptable salts thereof. Compounds according to the invention are useful in one or more aspects to inhibit farnesyl transferase, or to treat malaria, neoplasia, a hyperproliferative disease state or arthritis, including rheumaroid arthritis or osteoarthritis.</p>
申请公布号 WO2006102159(A2) 申请公布日期 2006.09.28
申请号 WO2006US09861 申请日期 2006.03.17
申请人 YALE UNIVERSITY;UNIVERSITY OF SOUTH FLORIDA;UNIVERSITY OF WASHINGTON;SEBTI, SAID;HAMILTON, ANDREW;BUCKNER, FREDERICK;GLENN, MATTHEW;VOORHIS, WESLEY, VAN 发明人 HAMILTON, ANDREW;BUCKNER, FREDERICK;GLENN, MATTHEW;VOORHIS, WESLEY, VAN
分类号 A61K31/59 主分类号 A61K31/59
代理机构 代理人
主权项
地址